Man­u­fac­tur­ing roundup: Lon­za to man­u­fac­ture two new FDA-ap­proved ther­a­pies in Hous­ton; Ei­sai fin­ish­es project in Japan

Man­u­fac­tur­ing gi­ant Lon­za can add more FDA-ap­proved ther­a­pies to its reper­toire.

The com­pa­ny an­nounced that two ther­a­pies man­u­fac­tured at its Hous­ton site, Zyn­te­glo and Skysona …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.